Priority claimed from 06/12/2019; Application No. : 88718579 ;United States of America
Goods or services claimed
IR DIVISION Pharmaceutical and biological preparations for human use; pharmaceutical and biological preparations to prevent and treat fungal infections and diseases.
Similar marks in class 5, same issue
- NEX-T Priority claimed from 08/12/2020; Application No. : 90366677 ;United States of America similar · Bristol-Myers Squibb Company
- XTESO Priority claimed from 19/01/2023; Application No. : 97760212 ;United States of America similar · Slayback Pharma Limited Liability Company
- TYKRUVA Priority claimed from 16/12/2020; Application No. : 90387051 ;United States of America similar · Bristol-Myers Squibb Company
- PREVDUO Priority claimed from 30/11/2022; Application No. : 97698414 ;United States of America similar · Slayback Pharma Limited Liability Company
Found by the same matcher that powers Brand Watch: identical, contained, near-spellings and sounds-alike names.
What "advertised" means for Priority claimed from 06/12/2019; Application No. : 88718579 ;United States of America
Advertised is not registered. The Registry examined the application, found no bar (or the applicant overcame the objection), and published it. Registration follows only if no opposition is filed within four months, or if an opposition fails. Until the certificate issues, the applicant may use ™ but not ®. Our guide to trademark status meanings explains each stage, and how long registration takes gives realistic timelines.
Source and corrections. Details are reproduced as advertised by the Registrar of Trade Marks in the Trade Marks Journal (a public record) and may contain errors of transcription. Applicants may ask for a correction or removal of their entry by writing to mehak@trademarkindia.pro. This page is information, not legal advice and not a solicitation.